Regulation of differentiated properties and proliferation of arterial smooth muscle cells.

D uring recent years, it has become increasingly evident that arterial smooth muscle cells occur in at least two distinct states, usually referred to as a synthetic and a contractile phenotype. Synthetic-state cells have a fibroblast-like appearance, and their main functions are to proliferate and to produce extracellular matrix components. They are found in the embryo and the young growing organism, where they take part in the formation of the vessel wall. Contractile-state cells have a musclelike appearance and contract in response to chemical and mechanical stimuli. They predominate in the vessels of adults and are primarily involved in the control of blood pressure and flow. However, these cells are able to return to a synthetic phenotype, and this appears to be an important early event in atherogenesis. This review briefly summarizes the present knowledge concerning the regulation of differentiated properties and proliferation of arterial smooth muscle cells. Most of the discussion will deal with studies on cultured cells, which so far are the most abundant. Particular attention will be paid to the role of extracellular matrix components like fibronectin and laminin and of polypeptide mitogens like platelet-derived growth factor (PDGF). It is believed that future studies in this area will help to widen our understanding of vasculogenesis and the initial stages in the pathogenesis of atherosclerosis.

[1]  D. Daret,et al.  Prostacyclin production by cultured smooth muscle cells from atherosclerotic rabbit aorta , 1980, Nature.

[2]  C. Dalsgaard,et al.  Stimulation of connective tissue cell growth by substance P and substance K , 1985, Nature.

[3]  G. Owens,et al.  Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation , 1986, The Journal of cell biology.

[4]  R. Wissler The cellular pathobiology of atherosclerosis in 1983. , 1985, Advances in experimental medicine and biology.

[5]  P. Wirth,et al.  Regulation of alpha-smooth muscle actin and other polypeptides in proliferating and density-arrested vascular smooth muscle cells. , 1990, Journal of cellular physiology.

[6]  C. Heldin,et al.  Demonstration of stimulatory effects of platelet-derived growth factor on cultivated rat arterial smooth muscle cells. Differences between cells from young and adult animals. , 1983, Experimental cell research.

[7]  M. Caton,et al.  Prostaglandins and thromboxanes. , 1979, Progress in medicinal chemistry.

[8]  Stephen M. Schwartz,et al.  Developmentally regulated production of platelet-derived growth factor-like molecules , 1984, Nature.

[9]  Richard O. Hynes,et al.  Integrins: A family of cell surface receptors , 1987, Cell.

[10]  Gary R. Grotendorst,et al.  Platelet‐derived growth factor is a chemoattractant for vascular smooth muscle cells , 1982, Journal of cellular physiology.

[11]  O. Kocher,et al.  Cytodifferentiation and expression of alpha-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state. , 1989, Arteriosclerosis.

[12]  J. Klarlund Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins , 1985, Cell.

[13]  P. Needleman,et al.  Arachidonic acid metabolism. , 1986, Annual review of biochemistry.

[14]  S. Moncada Prostacyclin and arterial wall biology. , 1982, Arteriosclerosis.

[15]  R. Alexander,et al.  Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. , 1986, The Journal of biological chemistry.

[16]  D. Cochran,et al.  Effect of heparin on vascular smooth muscle cells. II. Specific protein synthesis , 1985, Journal of cellular physiology.

[17]  D. Cochran,et al.  Heparin modulates the secretion of a major excreted protein-like molecule by vascular smooth muscle cells. , 1988, Biochimica et biophysica acta.

[18]  D. Payan Receptor-mediated mitogenic effects of substance P on cultured smooth muscle cells. , 1985, Biochemical and biophysical research communications.

[19]  R. Bryant,et al.  Characterization of 11-HETE and 15-HETE, together with prostacyclin, as major products of the cyclooxygenase pathway in cultured rat aorta smooth muscle cells. , 1983, Journal of lipid research.

[20]  C. Heldin,et al.  Platelet-derived growth factor , 1985, Molecular and Cellular Endocrinology.

[21]  A. Chobanian,et al.  Growth factor expression in aorta of normotensive and hypertensive rats. , 1989, The Journal of clinical investigation.

[22]  J. Chamley-Campbell,et al.  What controls smooth muscle phenotype? , 1981, Atherosclerosis.

[23]  A. Poole Proteoglycans in health and disease: structures and functions. , 1986, The Biochemical journal.

[24]  J. McDonald Receptors for extracellular matrix components. , 1989, The American journal of physiology.

[25]  J. Campbell,et al.  Endothelial cell influences on vascular smooth muscle phenotype. , 1986, Annual review of physiology.

[26]  R. Ross The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[27]  S. Schwartz,et al.  Interactions of vascular wall cells with collagen gels. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[28]  M. Moskowitz,et al.  Stimulation of aortic smooth muscle cell mitogenesis by serotonin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Griesmacher,et al.  A heparin-binding protein involved in inhibition of smooth-muscle cell proliferation. , 1988, The Biochemical journal.

[30]  O. Kocher,et al.  Expression of actin mRNAs in rat aortic smooth muscle cells during development, experimental intimal thickening, and culture. , 1986, Differentiation; research in biological diversity.

[31]  G. Gabbiani,et al.  Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. , 1985, The Journal of clinical investigation.

[32]  J. Mcgiff Prostaglandins, prostacyclin, and thromboxanes. , 1981, Annual review of pharmacology and toxicology.

[33]  R. Reddick,et al.  Smooth Muscle Cell Proliferation in Response to Endothelial Injury in Coronary Arteries of Normal and von Willebrand's Disease Swine , 1984, Arteriosclerosis.

[34]  A. Gown,et al.  Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. , 1986, The American journal of pathology.

[35]  V. Koteliansky,et al.  Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent , 1989, The Journal of cell biology.

[36]  M. R. Murray,et al.  A bibliography of the research in tissue culture 1884-1950 : an index to the literature of the living cell cultivated in vitro , 1953 .

[37]  G. Cherqui,et al.  Leukotriene D4-induced proliferation of glomerular epithelial cells: PKC- and Na+-H+ exchanger-mediated response. , 1989, The American journal of physiology.

[38]  J. Chamley-Campbell,et al.  INVITED REVIEW: THE CELLULAR PATHOBIOLOGY OF ATHEROSCLEROSIS , 1981, Pathology.

[39]  S. Takebayashi,et al.  Effects of collagen matrix on proliferation and differentiation of vascular smooth muscle cells in vitro. , 1990, Experimental and molecular pathology.

[40]  S. Dower,et al.  Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. , 1989, Science.

[41]  K. Yamada,et al.  Cell surface receptors for extracellular matrix components. , 1990, Biochimica et biophysica acta.

[42]  C. Stiles,et al.  Regulation of cytoskeletal architecture by platelet-derived growth factor, insulin and epidermal growth factor. , 1984, Experimental cell research.

[43]  B. Kommerell,et al.  Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis of cyclooxygenase. , 1985, The Journal of clinical investigation.

[44]  T. Deuel,et al.  Polypeptide growth factors: roles in normal and abnormal cell growth. , 1987, Annual review of cell biology.

[45]  D. Daret,et al.  Prostacyclin synthesis by proliferative aortic smooth muscle cells. A kinetic in vivo and in vitro study. , 1984, Atherosclerosis.

[46]  P. Mosse,et al.  Balloon Catheter Injury to Rabbit Carotid Artery: I. Changes in Smooth Muscle Phenotype , 1989, Arteriosclerosis.

[47]  Wickremasinghe Rg The role of prostaglandins in the regulation of cell proliferation. , 1988 .

[48]  H. Weiss,et al.  Human vascular smooth muscle cells in culture: growth characteristics and protein pattern by use of serum-free media supplements. , 1990, European journal of cell biology.

[49]  R. Silverstein,et al.  Thrombospondin: a versatile multifunctional glycoprotein. , 1986, Arteriosclerosis.

[50]  M. Yanagisawa,et al.  The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[51]  C. Heldin,et al.  Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth state-dependent manner , 1988, The Journal of cell biology.

[52]  A. Vaheri,et al.  Fibronectin and atherosclerosis. , 2009, Acta medica Scandinavica. Supplementum.

[53]  J. Thyberg,et al.  Effects of colchicine on DNA synthesis, endocytosis and fine structure of cultivated arterial smooth muscle cells. , 1983, Experimental cell research.

[54]  E. Ruoslahti,et al.  Extracellular matrices and cell adhesion. , 1985, Arteriosclerosis.

[55]  E. Brown,et al.  Angiotensin II rapidly increases phosphatidate-phosphoinositide synthesis and phosphoinositide hydrolysis and mobilizes intracellular calcium in cultured arterial muscle cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[56]  E. Ruoslahti,et al.  A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Y. Hirata,et al.  Endothelin is a potent mitogen for rat vascular smooth muscle cells. , 1989, Atherosclerosis.

[58]  J. Vandekerckhove,et al.  Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[59]  M. Peach,et al.  Angiotensin II Induces Hypertrophy, not Hyperplasia, of Cultured Rat Aortic Smooth Muscle Cells , 1988, Circulation research.

[60]  M. Lagarde,et al.  Metabolic interactions between eicosanoids in blood and vascular cells. , 1989, The Biochemical journal.

[61]  J. Lawler The structural and functional properties of thrombospondin. , 1986, Blood.

[62]  R. Chalkley,et al.  Characterization of actin mRNA levels during BC3H1 cell differentiation. , 1986, The Journal of biological chemistry.

[63]  C. Heldin,et al.  Structural and functional aspects of the receptors for platelet-derived growth factor. , 1989, Progress in growth factor research.

[64]  J. Thyberg,et al.  Phenotype modulation in primary cultures of smooth-muscle cells from rat aorta. Synthesis of collagen and elastin. , 1986, Differentiation; research in biological diversity.

[65]  W. Moolenaar Effects of growth factors on intracellular pH regulation. , 1986, Annual review of physiology.

[66]  K. Yamada,et al.  Vitronectin exists in two structurally and functionally distinct forms in human plasma. , 1989, Biochimica et biophysica acta.

[67]  J. Vandekerckhove,et al.  Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. , 1984, The Journal of clinical investigation.

[68]  W. Frazier Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells , 1987, The Journal of cell biology.

[69]  B. Caleb,et al.  Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells [published erratum appears in J Cell Biol 1990 Mar;110(3):863] , 1989, The Journal of cell biology.

[70]  Hans Michael Piper,et al.  Cell Culture Techniques in Heart and Vessel Research , 1990, Springer Berlin Heidelberg.

[71]  S. Singer,et al.  Direct morphological demonstration of the coexistence of vimentin and desmin in the same intermediate filaments of vascular smooth muscle cells. , 1987, Journal of submicroscopic cytology.

[72]  S. Kawamoto,et al.  Characterization of myosin heavy chains in cultured aorta smooth muscle cells. A comparative study. , 1987, Journal of Biological Chemistry.

[73]  M. Karnovsky,et al.  Structural determinants of heparin's growth inhibitory activity. Interdependence of oligosaccharide size and charge. , 1989, The Journal of biological chemistry.

[74]  S. Inoue Ultrastructure of basement membranes. , 1989, International review of cytology.

[75]  O. Kocher,et al.  Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells. , 1986, Human pathology.

[76]  M. Moskowitz,et al.  Serotonin receptor-mediated stimulation of bovine smooth muscle cell prostacyclin synthesis and its modulation by platelet-derived growth factor. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[77]  H. Ditschuneit,et al.  Interaction of receptors for insulin-like growth factor I, platelet-derived growth factor, and fibroblast growth factor in rat aortic cells. , 1987, Endocrinology.

[78]  C. Bonne,et al.  Differential effects of leukotrienes B4 and C4 on bovine aortic endothelial cell proliferation in vitro. , 1987, Prostaglandins.

[79]  G. Owens,et al.  Differential effect of platelet-derived growth factor- versus serum-induced growth on smooth muscle alpha-actin and nonmuscle beta-actin mRNA expression in cultured rat aortic smooth muscle cells. , 1989, The Journal of biological chemistry.

[80]  V. Koteliansky,et al.  Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima of human arteries. , 1987, Atherosclerosis.

[81]  P. Dartsch,et al.  Growth characteristics and cytoskeletal organization of cultured smooth muscle cells from human primary stenosing and restenosing lesions. , 1990, Arteriosclerosis.

[82]  H. Sarau,et al.  The signal transduction system of the leukotriene D4 receptor. , 1989, Trends in pharmacological sciences.

[83]  G. King,et al.  Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. , 1989, Molecular endocrinology.

[84]  N. E. Owen Effect of prostaglandin E1 on DNA synthesis in vascular smooth muscle cells. , 1986, The American journal of physiology.

[85]  P. Ghezzi,et al.  Platelet derived growth factor induces ornithine decarboxylase activity in NIH 3T3 cells. , 1985, Biochemical and Biophysical Research Communications - BBRC.

[86]  G. Pinkus,et al.  Immunohistochemical localization of smooth muscle myosin in normal human tissues. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[87]  P. Rubenstein,et al.  Induction of vascular smooth muscle alpha-isoactin expression in BC3H1 cells. , 1984, The Journal of biological chemistry.

[88]  M. Yanagisawa,et al.  A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. , 1989, The Journal of biological chemistry.

[89]  H. Erickson,et al.  Binding of hexabrachion (tenascin) to the extracellular matrix and substratum and its effect on cell adhesion. , 1990, Journal of cell science.

[90]  J. L. Alford,et al.  Developmental changes in collagen and elastin biosynthesis in the porcine aorta. , 1986, Developmental biology.

[91]  G. Owens,et al.  Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells , 1988, The Journal of cell biology.

[92]  T. Deuel,et al.  Human platelet-derived growth factor. Purification and resolution into two active protein fractions. , 1981, The Journal of biological chemistry.

[93]  J. Thyberg,et al.  Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells , 1988, The Journal of cell biology.

[94]  M. Hosang Suramin binds to platelet‐derived growth factor and inhibits its biological activity , 1985, Journal of cellular biochemistry.

[95]  D. Gospodarowicz,et al.  Basic fibroblast growth factor: expression in cultured bovine vascular smooth muscle cells. , 1988, European journal of cell biology.

[96]  D. Cochran,et al.  Effect of heparin on vascular smooth muscle cells. I. Cell metabolism , 1985, Journal of cellular physiology.

[97]  J. G. Leslie,et al.  Elastin structure, biosynthesis, and relation to disease states. , 1981, The New England journal of medicine.

[98]  M. Karnovsky,et al.  Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase. , 1982, The Journal of biological chemistry.

[99]  S. Shears,et al.  Metabolism of the inositol phosphates produced upon receptor activation. , 1989, The Biochemical journal.

[100]  C. Dalsgaard,et al.  Neuropeptides as growth factors. Possible roles in human diseases , 1989, Regulatory Peptides.

[101]  M. Berridge Inositol trisphosphate and diacylglycerol as second messengers. , 1984, The Biochemical journal.

[102]  R F Doolittle,et al.  Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. , 1983, Science.

[103]  G. Bondjers,et al.  Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.

[104]  D. Mosher Physiology of thrombospondin. , 1990, Annual review of medicine.

[105]  K. Weber,et al.  Co-existence of vimentin and desmin type intermediate filaments in a subpopulation of adult rat vascular smooth muscle cells growing in primary culture. , 1982, Experimental cell research.

[106]  W. Pallie Embryology of the Human Arterial System (Arteriogenesis) , 1980 .

[107]  M. Jokinen,et al.  Animal models in atherosclerosis research. , 1985, Experimental and molecular pathology.

[108]  F. Dieterlen‐Lièvre,et al.  Vasculogenesis in the early quail blastodisc as studied with a monoclonal antibody recognizing endothelial cells. , 1987, Development.

[109]  L. Matrisian,et al.  Differential effects of lysosomotropic amines and polyamines on processing and biological activity of EGF. , 1984, Experimental cell research.

[110]  L. Hokin,et al.  Role of phosphoinositides in transmembrane signaling. , 1990, Physiological reviews.

[111]  G. Sonenshein,et al.  Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. , 1989, The Journal of biological chemistry.

[112]  M. Denis,et al.  Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. , 1987, Journal of immunology.

[113]  D. Hood,et al.  Epidermal growth factor-mediated effects on equine vascular smooth muscle cells. , 1988, The American journal of physiology.

[114]  P. Halushka,et al.  Thromboxane, prostaglandin and leukotriene receptors. , 1989, Annual review of pharmacology and toxicology.

[115]  H. Antoniades,et al.  Platelet-derived growth factor binds specifically to receptors on vascular smooth muscle cells and the binding becomes nondissociable. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[116]  R. Rappaport,et al.  Establishment of the mechanism of cytokinesis in animal cells. , 1986, International review of cytology.

[117]  T. Libermann,et al.  Regulation of cell proliferation by epidermal growth factor. , 1983, CRC critical reviews in biochemistry.

[118]  C. Heldin,et al.  Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[119]  J. Schlessinger The epidermal growth factor receptor as a multifunctional allosteric protein. , 1988, Biochemistry.

[120]  Y. Nishizuka,et al.  Phosphatidylinositol turnover in receptor mechanism and signal transduction. , 1985, Annual review of pharmacology and toxicology.

[121]  R. Ross,et al.  Platelet-derived growth factor and its role in health and disease. , 1990, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[122]  H. F. Epstein,et al.  Muscle development--molecular and cellular control , 1982 .

[123]  A. Gown,et al.  Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. , 1986, Arteriosclerosis.

[124]  R. Timpl,et al.  Structure, development, and molecular pathology of basement membranes. , 1986, International review of experimental pathology.

[125]  E. Edelman,et al.  Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[126]  A. Ben-Ze'ev Cell shape, the complex cellular networks, and gene expression. Cytoskeletal protein genes as a model system. , 1985, Cell and muscle motility.

[127]  J. Thyberg,et al.  Integrin-type fibronectin receptors of rat arterial smooth muscle cells: isolation, partial characterization and role in cytoskeletal organization and control of differentiated properties. , 1989, Differentiation; research in biological diversity.

[128]  R. Alexander,et al.  Vasoactive effects of growth factors. , 1989, Biochemical pharmacology.

[129]  Gerrity Rg,et al.  The aortic tunica media of the developing rat. I. Quantitative stereologic and biochemical analysis. , 1975 .

[130]  G. Owens,et al.  Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. , 1989, The American journal of physiology.

[131]  R. Majack Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures , 1987, The Journal of cell biology.

[132]  C. Heldin,et al.  Rat skeletal myoblasts and arterial smooth muscle cells express the gene for the A chain but not the gene for the B chain (c-sis) of platelet-derived growth factor (PDGF) and produce a PDGF-like protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[133]  R. Gerrity,et al.  The aortic tunica media of the developing rat. I. Quantitative stereologic and biochemical analysis. , 1975, Laboratory investigation; a journal of technical methods and pathology.

[134]  B. Weksler,et al.  Cholesterol metabolism is altered by hydrolytic metabolites of prostacyclin in arterial smooth muscle cells. , 1986, Journal of lipid research.

[135]  W. Franke,et al.  High frequency of cytokeratin-producing smooth muscle cells in human atherosclerotic plaques. , 1989, Differentiation; research in biological diversity.

[136]  B. Fredholm,et al.  Induction of ornithine decarboxylase activity and putrescine synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. , 1987, Experimental cell research.

[137]  C. Heldin,et al.  Platelet-derived growth factor: purification and partial characterization. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[138]  B. Voss,et al.  Localization of collagen types I, III, IV and V, fibronectin and laminin in human arteries by the indirect immunofluorescence method. , 1986, Pathology, research and practice.

[139]  K. Mark,et al.  Antagonistic effects of laminin and fibronectin on the expression of the myogenic phenotype , 1989 .

[140]  G. Gabbiani,et al.  A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation , 1986, The Journal of cell biology.

[141]  E. Weber,et al.  Inducibleendothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells , 1990 .

[142]  T. Barrett,et al.  sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[143]  A. Pegg,et al.  The role of polyamines in somatomedin‐stimulated differentiation of L6 myoblasts , 1984, Journal of cellular physiology.

[144]  G. Hansson,et al.  Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro. , 1988, Experimental cell research.

[145]  G. Owens,et al.  Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells , 1988, The Journal of cell biology.

[146]  T. McCaffrey,et al.  Aging and arteriosclerosis. The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity , 1988, The Journal of experimental medicine.

[147]  Johannes A. G. Rhodin,et al.  Architecture of the Vessel Wall , 1980 .

[148]  J. Pouysségur The growth factor-activatable Na+/H+ exchange system: a genetic approach , 1985 .

[149]  B. Herman,et al.  Platelet-derived growth factor-induced alterations in vinculin distribution in porcine vascular smooth muscle cells. , 1987, Cell motility and the cytoskeleton.

[150]  V. Dzau,et al.  Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[151]  R. Eddy,et al.  cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines , 1986, Nature.

[152]  J. Thyberg,et al.  Phenotype modulation in primary cultures of arterial smooth-muscle cells. Dual effect of prostaglandin E1. , 1984, Differentiation; research in biological diversity.

[153]  H. Hämmerle,et al.  Cytocontractile structures and proteins of smooth muscle cells during the formation of experimental lesions. , 1987, Experimental and molecular pathology.

[154]  R. Ross,et al.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[155]  R. Rosenberg,et al.  Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor , 1987, Journal of cellular physiology.

[156]  J. Fleisch,et al.  Leukotriene receptor antagonists as potential therapeutic agents. , 1989, Annual review of pharmacology and toxicology.

[157]  R. Ross,et al.  THE SMOOTH MUSCLE CELL I. In Vivo Synthesis of Connective Tissue Proteins , 1971 .

[158]  W. Risau,et al.  Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. , 1988, Developmental biology.

[159]  R. Timpl,et al.  Role of laminin and fibronectin in selecting myogenic versus fibrogenic cells from skeletal muscle cells in vitro. , 1986, Developmental biology.

[160]  G. Milo,et al.  Polyunsaturated fatty acids, vitamin E, and the proliferation of aortic smooth muscle cells. , 1979, Lipids.

[161]  H. Evans On the development of the aortae, cardinal and umbilical veins, and the other blood vessels of vertebrate embryos from capillaries , 1909 .

[162]  V. Tertov,et al.  Content and localization of fibronectin in normal intima, atherosclerotic plaque, and underlying media of human aorta. , 1984, Atherosclerosis.

[163]  W. Smith,et al.  The eicosanoids and their biochemical mechanisms of action. , 1989, The Biochemical journal.

[164]  R. Ross,et al.  Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. , 1984, The American journal of pathology.

[165]  M. Clozel,et al.  Specific binding of endothelin on human vascular smooth muscle cells in culture. , 1989, The Journal of clinical investigation.

[166]  M. Kang,et al.  Correlation between fibronectin and its receptor in chick myoblast differentiation , 1990, Journal of cellular physiology.

[167]  B. Geiger,et al.  Epidermal growth factor induces redistribution of actin and alpha-actinin in human epidermal carcinoma cells. , 1981, Experimental cell research.

[168]  J. Boissel,et al.  Growth‐stimulating effect of catecholamines on rat aortic smooth muscle cells in culture , 1983, Journal of cellular physiology.

[169]  M. Hollenberg,et al.  Epidermal growth factor stimulation of prostacyclin production by cultured aortic smooth muscle cells: Requirement for increased cellular calcium levels , 1989, Journal of cellular physiology.

[170]  J. Thyberg,et al.  Leukotrienes stimulate initiation of DNA synthesis in cultured arterial smooth muscle cells. , 1987, Journal of cell science.

[171]  M. Bienkowski,et al.  Regulation of prostaglandin H synthase mRNA levels and prostaglandin biosynthesis by platelet-derived growth factor. , 1989, The Journal of biological chemistry.

[172]  B. Ransil,et al.  Vascular smooth muscle cell kinetics: a new assay for studying patterns of cellular proliferation in vivo. , 1979, Science.

[173]  Clowes Aw,et al.  Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[174]  R. Gryglewski,et al.  Prostaglandins, platelets, and atherosclerosis. , 1980, CRC critical reviews in biochemistry.

[175]  R. Gerrity,et al.  The aortic tunica media of the developing rat. II. Incorporation by medial cells 3-H-proline into collagen and elastin: autoradiographic and chemical studies. , 1975, Laboratory investigation; a journal of technical methods and pathology.

[176]  R. Ross,et al.  Purification of human platelet-derived growth factor. , 1985, Methods in enzymology.

[177]  J. Thyberg,et al.  Cell surface components and growth regulation in cultivated arterial smooth muscle cells. , 1983, Journal of cell science.

[178]  P. Bornstein,et al.  Heparin and related glycosaminoglycans modulate the secretory phenotype of vascular smooth muscle cells , 1984, The Journal of cell biology.

[179]  C. Franzblau,et al.  Elastin mRNA levels and insoluble elastin accumulation in neonatal rat smooth muscle cell cultures. , 1988, Biochemistry.

[180]  L. Jonasson,et al.  Smooth muscle cells express Ia antigens during arterial response to injury. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[181]  J. Schlessinger,et al.  Fibronectin delays the fusion of L6 myoblasts. , 1979, Experimental cell research.

[182]  E. Rozengurt,et al.  The role of cytoplasmic microtubules in the regulation of the activity of peptide growth factors. , 1980, Advances in enzyme regulation.

[183]  J. Thyberg,et al.  Phenotype modulation in primary cultures of arterial smooth-muscle cells: reorganization of the cytoskeleton and activation of synthetic activities. , 1985, Differentiation; research in biological diversity.

[184]  Gary R. Grotendorst,et al.  Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[185]  L. Cantley,et al.  Mitogens and ion fluxes. , 1988, Annual review of physiology.

[186]  R. Ross,et al.  Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[187]  J. Thyberg,et al.  Electron microscopic observations on the formation of elastic fibers in primary cultures of aortic smooth muscle cells. , 1977, Journal of ultrastructure research.

[188]  Yanagisawa Masashi,et al.  Endothelin, a novel endothelium-derived peptide: Pharmacological activities, regulation and possible roles in cardiovascular control , 1989 .

[189]  C. Heldin,et al.  Platelet-derived growth factor: three isoforms and two receptor types. , 1989, Trends in genetics : TIG.

[190]  J. Smith,et al.  Vanadium ions stimulate DNA synthesis in Swiss mouse 3T3 and 3T6 cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[191]  R. Rutherford,et al.  Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate , 1976, The Journal of cell biology.

[192]  J. Herbert,et al.  Heparin interactions with cultured human vascular endothelial and smooth muscle cells: Incidence on vascular smooth muscle cell proliferation , 1989, Journal of cellular physiology.

[193]  J. Winkles,et al.  Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[194]  H. Erickson,et al.  Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. , 1989, Annual review of cell biology.

[195]  P. Vischer,et al.  A possible role of catecholamines in atherogenesis and subsequent complications of atherosclerosis. , 1987, Experimental pathology.

[196]  D. Carey,et al.  Inhibition of proteoglycan synthesis alters extracellular matrix deposition, proliferation, and cytoskeletal organization of rat aortic smooth muscle cells in culture , 1989, The Journal of cell biology.

[197]  Y. Yoshikawa,et al.  Role of macrophages in atherosclerosis. Sequential observations of cholesterol-induced rabbit aortic lesion by the immunoperoxidase technique using monoclonal antimacrophage antibody. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[198]  C. Heldin,et al.  Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types. , 1988, The EMBO journal.

[199]  R. Ardaillou,et al.  Leukotriene C4 binds to human glomerular epithelial cells and promotes their proliferation in vitro. , 1985, The Journal of clinical investigation.

[200]  T. Maciag,et al.  Hormonal requirements for growth of arterial smooth muscle cells in vitro: and endocrine approach to atherosclerosis. , 1981, Science.

[201]  E. Ruoslahti,et al.  Purification and characterization of vitronectin. , 1987, Methods in enzymology.

[202]  H. Hämmerle,et al.  Expression of smooth muscle myosin in relation to growth kinetics of cultured aortic smooth muscle cells. , 1988, Experimental cell research.

[203]  D. Clemmons Interaction of circulating cell‐derived and plasma growth factors in stimulating cultured smooth muscle cell replication , 1984, Journal of cellular physiology.

[204]  R. Alexander,et al.  Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction. , 1985, The Journal of clinical investigation.

[205]  A. Faerman,et al.  A 90-kd surface antigen from a subpopulation of smooth muscle cells from human atherosclerotic lesions. , 1989, The American journal of pathology.

[206]  C. Reilly Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin , 1990, Journal of cellular physiology.

[207]  Julie H. Campbell,et al.  Vascular smooth muscle in culture , 1987 .

[208]  B. Weksler,et al.  Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells. , 1982, The Journal of clinical investigation.

[209]  L. Chen,et al.  Alteration in cell surface LETS protein during myogenesis , 1977, Cell.

[210]  S. Yamamoto,et al.  Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. , 1990, Molecular pharmacology.

[211]  H. Kanaide,et al.  Metabolism of glycosaminoglycans of cultured rat aortic smooth muscle cells altered during subculture. , 1983, British journal of experimental pathology.

[212]  M. Sporn,et al.  Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.

[213]  M. Waterfield,et al.  Platelet-derived growth factor elicits cyclic AMP accumulation in swiss 3T3 cells: Role of prostaglandin production , 1983, Cell.

[214]  R. Alexander,et al.  Vasoconstriction: a new activity for platelet-derived growth factor. , 1986, Science.

[215]  B. Rollins,et al.  Platelet-derived growth factor generates at least two distinct intracellular signals that modulate gene expression. , 1988, Cold Spring Harbor symposia on quantitative biology.

[216]  M. Sporn,et al.  Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells , 1986, The Journal of cell biology.

[217]  R. Mayne Collagenous proteins of blood vessels. , 1986, Arteriosclerosis.

[218]  Matthias Chiquet,et al.  Tenascin interferes with fibronectin action , 1988, Cell.

[219]  P. Majerus Arachidonate metabolism in vascular disorders. , 1983, The Journal of clinical investigation.

[220]  N. Tonks,et al.  Protein tyrosine dephosphorylation and signal transduction. , 1989, Trends in biochemical sciences.

[221]  P. Libby,et al.  Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. , 1988, The New England journal of medicine.

[222]  R. Alexander,et al.  Myosin in cultured vascular smooth muscle cells: immunofluorescence and immunochemical studies of alterations in antigenic expression , 1984, The Journal of cell biology.

[223]  R. Tucker Role of microtubules and centrioles in growth regulation of mammalian cells. , 1983, Cell and muscle motility.

[224]  S. Crooke,et al.  Leukotriene D4 treatment of bovine aortic endothelial cells and murine smooth muscle cells in culture results in an increase in phospholipase A2 activity. , 1986, The Journal of biological chemistry.

[225]  R. Ross,et al.  Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens , 1981, The Journal of cell biology.

[226]  J. Thyberg,et al.  Changes in expression and organization of smooth-muscle-specific alpha-actin during fibronectin-mediated modulation of arterial smooth muscle cell phenotype. , 1990, Differentiation; research in biological diversity.

[227]  C. Heldin,et al.  Similar action of platelet‐derived growth factor and epidermal growth factor in the prereplicative phase of human fibroblasts suggests a common intracellular pathway , 1985, Journal of cellular physiology.

[228]  Yanagisawa Masashi,et al.  Molecular biology and biochemistry of the endothelins. , 1989 .

[229]  O. Kocher,et al.  Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimal thickening. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[230]  A. Pegg Recent advances in the biochemistry of polyamines in eukaryotes. , 1986, The Biochemical journal.

[231]  R. Ross,et al.  Platelet-derived growth factor. II. Specific binding to cultured cells. , 1982, Journal of Biological Chemistry.

[232]  J. Rosenbloom [9] Elastin: An overview , 1987 .

[233]  S Grinstein,et al.  Na+/H+ exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation. , 1989, Biochimica et biophysica acta.

[234]  W. Mckeehan,et al.  Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[235]  A. Bobik,et al.  Growth factor activity of endothelin on vascular smooth muscle. , 1990, The American journal of physiology.

[236]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.

[237]  V. Dixit,et al.  Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation , 1988, The Journal of cell biology.

[238]  T. Resink,et al.  Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. , 1989, Hypertension.

[239]  B. Caleb,et al.  Binding and internalization of heparin by vascular smooth muscle cells , 1985, Journal of cellular physiology.

[240]  J. Thyberg,et al.  Effects of leukotrienes on phenotypic properties and growth of arterial smooth muscle cells in primary culture. , 1989, Journal of cell science.

[241]  C. Heldin,et al.  Isoform‐specific induction of actin reorganization by platelet‐derived growth factor suggests that the functionally active receptor is a dimer. , 1989, The EMBO journal.

[242]  P. Libby,et al.  Inducible interleukin-1 gene expression in human vascular smooth muscle cells. , 1986, The Journal of clinical investigation.

[243]  T. Sejersen,et al.  DNA synthesis induced by the neuropeptide substance K correlates to the level of myc-gene transcripts. , 1986, Biochemical and biophysical research communications.

[244]  P. Bornstein,et al.  Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[245]  Julie H. Campbell,et al.  Collagen synthesis by cultured rabbit aortic smooth-muscle cells. Alteration with phenotype. , 1990, The Biochemical journal.

[246]  E. Scarpini,et al.  Analysis of fibronectin expression during human muscle differentiation. , 1986, Basic and applied histochemistry.

[247]  L. Heickendorff The basement membrane of arterial smooth muscle cells. , 1989, APMIS. Supplementum.

[248]  A. Daoud,et al.  Association of DNA synthesis and apparent dedifferentiation of aortic smooth muscle cells in vitro. , 1970, Experimental and molecular pathology.

[249]  G. FitzGerald,et al.  Eicosanoid biosynthesis in human cardiovascular disease. , 1987, Human pathology.

[250]  R. Ross,et al.  Synthesis of connective tissue macromolecules by smooth muscle. , 1979, International review of connective tissue research.

[251]  G. Gabbiani,et al.  Correlation between the distribution of smooth muscle or non muscle myosins and alpha-smooth muscle actin in normal and pathological soft tissues. , 1988, Cell motility and the cytoskeleton.

[252]  A. Olsson,et al.  Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. , 1984, Atherosclerosis.

[253]  J. Campbell,et al.  Smooth muscle phenotypic expression in human carotid arteries. II. Atherosclerosis-free diffuse intimal thickenings compared with the media. , 1986, Arteriosclerosis.

[254]  R. Rosenberg,et al.  Heparin‐like molecules regulate the number of epidermal growth factor receptors on vascular smooth muscle cells , 1988, Journal of cellular physiology.

[255]  D. Stumpo,et al.  Effects of mitogens on ornithine decarboxylase activity and messenger RNA levels in normal and protein kinase C-deficient NIH-3T3 fibroblasts. , 1986, The Journal of biological chemistry.

[256]  H. Waldmann,et al.  Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies , 1985, The Journal of pathology.

[257]  Y. Yoshida,et al.  Increased production of prostacyclin (PGI2) by vascular intimal smooth muscle cells from atherosclerotic rabbit aorta. , 1988, Prostaglandins.

[258]  H. Ehrlich,et al.  Studies on vascular smooth muscle cells and dermal fibroblasts in collagen matrices. Effects of heparin. , 1986, Experimental cell research.

[259]  R. Ross,et al.  Platelet‐derived growth factor: Morphologic and biochemical studies of binding, internalization, and degradation , 1984, Journal of cellular physiology.

[260]  G. Gabbiani,et al.  Cytoskeletal remodeling of rat aortic smooth muscle cells in vitro: relationships to culture conditions and analogies to in vivo situations. , 1986, Journal of submicroscopic cytology.

[261]  G. Carpenter,et al.  EPIDERMAL GROWTH FACTOR * , 1982, The Journal of biological chemistry.

[262]  G. Milo,et al.  Fatty acids and their prostaglandin derivatives: inhibitors of proliferation in aortic smooth muscle cells. , 1977, Science.

[263]  W. Pledger,et al.  Platelet-derived growth factor-induced alterations in vinculin and actin distribution in BALB/c-3T3 cells , 1985, The Journal of cell biology.

[264]  P. Rubenstein,et al.  A vascular smooth muscle alpha-isoactin biosynthetic intermediate in BC3H1 cells. Identification of acetylcysteine at the NH2 terminus. , 1984, The Journal of biological chemistry.

[265]  R. Ross,et al.  The biology of platelet-derived growth factor , 1986, Cell.

[266]  B. Samuelsson Prostaglandins and Thromboxanes , 1977, NATO Advanced Study Institutes Series.

[267]  R. Alexander,et al.  Functional angiotensin II receptors in cultured vascular smooth muscle cells , 1982, The Journal of cell biology.

[268]  B. Fredholm,et al.  Adenosine receptor‐mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells , 1985, Journal of cellular physiology.

[269]  N. Morisaki,et al.  Lack of inhibition of DNA synthesis by prostaglandin I2 in cultured intimal smooth muscle cells from rabbits. , 1988, Atherosclerosis.

[270]  A. Strauch,et al.  Sequential expression of smooth muscle and sarcomeric alpha-actin isoforms during BC3H1 cell differentiation. , 1989, The Journal of biological chemistry.

[271]  K. Resch,et al.  Interleukin 1: more than a mediator between leukocytes. , 1988, Trends in pharmacological sciences.

[272]  J. Rosenbloom Elastin: an overview. , 1987, Methods in enzymology.

[273]  B. Samuelsson Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.

[274]  Julie H. Campbell,et al.  Smooth muscle phenotypic expression in human carotid arteries. I. Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[275]  R. Coffey,et al.  Transforming growth factor β regulation of cell proliferation , 1987, Journal of cellular physiology. Supplement.

[276]  O. Kocher,et al.  Cytoskeletal Features of Rat Aortic Cells during Development: An Electron Microscopic, Immunohistochemical, and Biochemical Study , 1985, Circulation research.

[277]  J. Vandekerckhove,et al.  Permanently proliferating rat vascular smooth muscle cell with maintained expression of smooth muscle characteristics, including actin of the vascular smooth muscle type , 1980, The Journal of cell biology.

[278]  S. Coughlin,et al.  Signal transduction by the platelet-derived growth factor receptor. , 1988, Cold Spring Harbor symposia on quantitative biology.

[279]  Akira,et al.  Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells , 1988, The Journal of cell biology.

[280]  D. Donoghue,et al.  Structure and function of platelet-derived growth factor (PDGF) and related proteins. , 1989, Biochimica et biophysica acta.

[281]  D. Clemmons Exposure to platelet-derived growth factor modulates the porcine aortic smooth muscle cell response to somatomedin-C. , 1985, Endocrinology.

[282]  C. Nathan,et al.  Secretory products of macrophages. , 1987, The Journal of clinical investigation.

[283]  Cotran Rs,et al.  The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation , 1989 .

[284]  C. Dalsgaard,et al.  Coupling between inositol phosphate formation and DNA synthesis in smooth muscle cells stimulated with neurokinin A , 1988, Journal of cellular physiology.

[285]  J. Campbell,et al.  Lipid accumulation in arterial smooth muscle cells. Influence of phenotype. , 1983, Atherosclerosis.

[286]  G. Owens,et al.  Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation. , 1986, The Journal of biological chemistry.

[287]  A. Gown,et al.  A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes , 1985, The Journal of cell biology.

[288]  J. Voorhees,et al.  Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytes , 1985, The British journal of dermatology.

[289]  R. Rosenberg,et al.  Heparin inhibition of smooth muscle cell proliferation: A cellular site of action , 1986, Journal of cellular physiology.

[290]  R. Cotran,et al.  The pathogenesis of atherosclerosis: atherogenesis and inflammation. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[291]  M. Majesky,et al.  Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta , 1990, The Journal of cell biology.

[292]  N. Morisaki,et al.  Effects of smooth muscle cell derived growth factor (SDGF) in combination with other growth factors on smooth muscle cells. , 1989, Atherosclerosis.

[293]  J. Campbell,et al.  Glycosaminoglycan synthesis by smooth muscle cells of differing phenotype and their response to endothelial cell conditioned medium. , 1990, Atherosclerosis.

[294]  T. Resink,et al.  Decreased susceptibility of cultured smooth muscle cells from SHR rats to growth inhibition by heparin , 1989, Journal of cellular physiology.

[295]  D. Gospodarowicz,et al.  Factors controlling the proliferative rate, final cell density, and life span of bovine vascular smooth muscle cells in culture , 1981, The Journal of cell biology.

[296]  T. Hunter A thousand and one protein kinases , 1987, Cell.

[297]  T. Nikkari,et al.  Characterization of the phenotype of smooth muscle cells in human fetal aorta on the basis of ultrastructure, immunofluorescence, and the composition of cytoskeletal and cytocontractile proteins. , 1988, Atherosclerosis.

[298]  P. Woll,et al.  A role for neuropeptides in the control of cell proliferation. , 1987, Developmental biology.

[299]  J. Thyberg,et al.  Attachment Substrates for Smooth Muscle Cells , 1990 .

[300]  R. A. Murphy,et al.  Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. , 1986, The Journal of biological chemistry.

[301]  Y. Nishizuka Studies and perspectives of protein kinase C. , 1986, Science.

[302]  N. Giles Induction of ornithine decarboxylase activity by insulin and growth factors is mediated by amino acids " , 2022 .

[303]  P. Libby,et al.  Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. , 1988, The Journal of clinical investigation.

[304]  E. Ruoslahti Fibronectin and its receptors. , 1988, Annual review of biochemistry.

[305]  M. Yanagisawa,et al.  Endothelin receptor is coupled to phospholipase C via a pertussis toxin-insensitive guanine nucleotide-binding regulatory protein in vascular smooth muscle cells. , 1990, The Journal of clinical investigation.

[306]  G. Gabbiani,et al.  Distribution of vimentin and desmin filaments in smooth muscle tissue of mammalian and avian aorta. , 1982, Experimental cell research.

[307]  G. Luk,et al.  8 – Polyamine Synthesis Inhibitors Act as both Inducers and Suppressors of Cell Differentiation , 1987 .

[308]  T. Barrett,et al.  Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[309]  T. Ishimitsu,et al.  Regulatory effects of eicosanoids on thymidine uptake by vascular smooth muscle cells of rats. , 1988, Prostaglandins.

[310]  R. Alexander,et al.  Endothelin stimulates diacylglycerol accumulation and activates protein kinase C in cultured vascular smooth muscle cells. , 1989, The Journal of biological chemistry.

[311]  P. Nestel,et al.  Metabolism of Atherogenic Lipoproteins by Smooth Muscle Cells of Different Phenotype in Culture , 1985, Arteriosclerosis.

[312]  R. Ross,et al.  Low density lipoprotein receptor-dependent prostaglandin synthesis in Swiss 3T3 cells stimulated by platelet-derived growth factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[313]  G. Carpenter,et al.  Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in quiescent BALB/c 3T3 cells , 1989, Molecular and cellular biology.

[314]  R. Timpl Structure and biological activity of basement membrane proteins. , 1989, European journal of biochemistry.

[315]  A. Otto Microtubules and the regulation of DNA synthesis in fibroblastic cells. (A minireview). , 1982, Cell biology international reports.

[316]  Paul Stroobant,et al.  Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus , 1983, Nature.

[317]  D. Clemmons,et al.  Evidence for a functional role of endogenously produced somatomedinlike peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells. , 1985, The Journal of clinical investigation.

[318]  F. Watt The extracellular matrix and cell shape , 1986 .

[319]  C. Heldin,et al.  Surface binding and internalization of platelet-derived growth factor in human fibroblasts. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[320]  S. Schwartz,et al.  Replication of smooth muscle cells in vascular disease. , 1986, Circulation research.

[321]  M. Bernfield,et al.  Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet‐derived growth factor , 1986, Journal of Cellular Physiology.

[322]  K. Kariya,et al.  Stimulation of phospholipase C-mediated hydrolysis of phosphoinositides by endothelin in cultured rabbit aortic smooth muscle cells. , 1989, Biochemical and biophysical research communications.

[323]  D. Smith,et al.  Eicosanoid effects on cell proliferation in vitro: relevance to atherosclerosis. , 1984, Prostaglandins, leukotrienes, and medicine.

[324]  R. Chiquet‐Ehrismann,et al.  Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis , 1986, Cell.

[325]  R. Timpl,et al.  Synthesis of type IV collagen and laminin in cultures of skeletal muscle cells and their assembly on the surface of myotubes. , 1982, Developmental biology.

[326]  C. Heldin,et al.  Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[327]  M. Lark,et al.  Modulation of proteoglycan metabolism by aortic smooth muscle cells grown on collagen gels. , 1986, Arteriosclerosis.

[328]  L. Jonasson,et al.  Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. , 1986, Clinical and experimental immunology.

[329]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[330]  G. Carpenter,et al.  Epidermal growth factor, its receptor, and related proteins. , 1986, Experimental cell research.

[331]  R. Rosenberg,et al.  An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells , 1985, The Journal of cell biology.

[332]  A. Horwitz,et al.  Cell surface receptors for extracellular matrix molecules. , 1987, Annual review of cell biology.

[333]  R. Alexander,et al.  Heterogeneity of myosin antigenic expression in vascular smooth muscle in vivo. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[334]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[335]  L. Cantley,et al.  Phosphoinositide metabolism and the control of cell proliferation. , 1989, Biochimica et biophysica acta.

[336]  O. Kocher,et al.  Arterial smooth muscle cells in vivo: relationship between actin isoform expression and mitogenesis and their modulation by heparin , 1988, The Journal of cell biology.

[337]  R. Zaragoza,et al.  Heparin inhibits Na(+)-H+ exchange in vascular smooth muscle cells. , 1990, The American journal of physiology.

[338]  G. Campbell,et al.  Balloon Catheter Injury to Rabbit Carotid Artery: II. Selective Increase in Reactivity to Some Vasoconstrictor Drugs , 1989, Arteriosclerosis.

[339]  H. Nakamura,et al.  Electron microscopic study of the prenatal development of the thoracic aorta in the rat. , 1988, The American journal of anatomy.

[340]  R. Ross,et al.  Platelet-derived Growth Factor , 2022 .

[341]  B. Westermark,et al.  A platelet factor stimulating human normal glial cells. , 1976, Experimental cell research.

[342]  B. Westermark,et al.  Influence of epidermal growth factor (EGF) on ruffling activity, pinocytosis and proliferation of cultivated human glia cells. , 1976, Experimental cell research.

[343]  N. Morisaki,et al.  Secretion of a new growth factor, smooth muscle cell derived growth factor, distinct from platelet derived growth factor by cultured rabbit aortic smooth muscle cells , 1988, FEBS letters.

[344]  T. Nikkari,et al.  Prostaglandins enhance the synthesis of glycosaminoglycans and inhibit the growth of rabbit aortic smooth muscle cells in culture. , 1980, Artery.

[345]  P. Bonin,et al.  Interleukin-1 promotes proliferation of vascular smooth muscle cells in coordination with PDGF or a monocyte derived growth factor. , 1989, Experimental cell research.

[346]  B. Kommerell,et al.  Evidence for coordinate, selective regulation of eicosanoid synthesis in platelet-derived growth factor-stimulated 3T3 fibroblasts and in HL-60 cells induced to differentiate into macrophages or neutrophils. , 1988, The Journal of biological chemistry.

[347]  K. Lau,et al.  Phosphotyrosyl protein phosphatases. , 1989, The Biochemical journal.

[348]  V. Dixit,et al.  Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. , 1987, The Journal of biological chemistry.

[349]  A. J. Valente,et al.  Cultured primate aortic smooth muscle cells express both the PDGF‐‐A and PDGF‐B genes but do not secrete mitogenic activity or dimeric platelet‐derived growth factor protein , 1988, Journal of cellular physiology.

[350]  A. Clowes,et al.  Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[351]  N. Joyce,et al.  Interaction of angiotensin II with functional smooth muscle cells in culture. , 1987, The American journal of physiology.

[352]  P. Libby,et al.  Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. , 1990, The Journal of clinical investigation.

[353]  E. Edelman,et al.  Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. , 1989, Arteriosclerosis.

[354]  A. Clowes,et al.  Suppression by heparin of smooth muscle cell proliferation in injured arteries , 1977, Nature.

[355]  M. Moskowitz,et al.  Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor , 1980, Nature.

[356]  M. Barnes,et al.  Collagens in atherosclerosis. , 1985, Collagen and related research.

[357]  M. Yanagisawa,et al.  Molecular biology and biochemistry of the endothelins. , 1989, Trends in pharmacological sciences.

[358]  I. Herman Extracellular matrix-cytoskeletal interactions in vascular cells. , 1987, Tissue & cell.

[359]  J. Thyberg,et al.  A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype. , 1989, Developmental biology.

[360]  A. A. Spector,et al.  Hydroxyeicosatetraenoic acids (HETEs). , 1988, Progress in lipid research.

[361]  P. Bornstein,et al.  Heparin regulates the collagen phenotype of vascular smooth muscle cells: induced synthesis of an Mr 60,000 collagen , 1985, The Journal of cell biology.

[362]  C. Littlewood,et al.  Endothelin stimulates DNA synthesis in Swiss 3T3 cells. Synergy with polypeptide growth factors. , 1989, The Biochemical journal.

[363]  A. Ullrich,et al.  Growth factor receptor tyrosine kinases. , 1988, Annual review of biochemistry.

[364]  B. Oakes,et al.  The synthesis of elastin, collagen, and glycosaminoglycans by high density primary cultures of neonatal rat aortic smooth muscle. An ultrastructural and biochemical study. , 1982, European journal of cell biology.

[365]  L. Ehrhart,et al.  Substratum influence on collagen and fibronectin biosynthesis by arterial smooth muscle cells in vitro , 1986, Journal of cellular physiology.

[366]  R. van Wijk,et al.  Cell cycle-dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin E1. , 1985, Experimental cell research.

[367]  H. Ziegler-Heitbrock The biology of the monocyte system. , 1989, European journal of cell biology.

[368]  S. Schwartz,et al.  Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[369]  A. Pardee G1 events and regulation of cell proliferation. , 1989, Science.

[370]  Y. Yazaki,et al.  Endothelin stimulates c‐fos and c‐myc expression and proliferation of vascular smooth muscle cells , 1988, FEBS letters.

[371]  R. Majack,et al.  Vascular smooth muscle cells express distinct transforming growth factor-beta receptor phenotypes as a function of cell density in culture. , 1989, The Journal of biological chemistry.

[372]  P. Libby,et al.  Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells , 1987, The Journal of experimental medicine.

[373]  Kathleen M. Smith,et al.  Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. , 1988, The Journal of clinical investigation.

[374]  P. Bornstein,et al.  Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells , 1985, The Journal of cell biology.

[375]  N. Morisaki,et al.  Cell cycle-dependent inhibition of DNA synthesis by prostaglandin I2 in cultured rabbit aortic smooth muscle cells. , 1988, Atherosclerosis.

[376]  J. Thyberg,et al.  The microtubular cytoskeleton and the initiation of DNA synthesis. , 1984, Experimental cell research.

[377]  C. Ashall,et al.  Fibronectin distribution in human aortic intima and atherosclerotic lesions: concentration of soluble and collagenase-releasable fractions. , 1986, Biochimica et biophysica acta.

[378]  M. Bissell,et al.  The Influence of Extracellular Matrix on Gene Expression: Is Structure the Message? , 1987, Journal of Cell Science.

[379]  A. Lipton,et al.  Platelets as a source of fibroblast growth-promoting activity. , 1974, Experimental cell research.

[380]  B. Berk,et al.  Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. , 1989, Hypertension.

[381]  R. Alexander,et al.  Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. , 1989, The Journal of biological chemistry.

[382]  A. Desmoulière,et al.  Detection of atherosclerotic plaque with two monoclonal antibodies. 2P1A2 monoclonal antibody is specific for smooth muscle cells in atherosclerotic plaque. , 1988, Atherosclerosis.

[383]  S. Dahlén,et al.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.

[384]  I. Herman,et al.  Regulation of Vascular Smooth Muscle Cell Growth by Endothelial‐Synthesized Extracellular Matrices , 1987, Arteriosclerosis.

[385]  C. Heldin,et al.  Induction of circular membrane ruffling on human fibroblasts by platelet-derived growth factor. , 1988, Experimental cell research.

[386]  D. Beeler,et al.  Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells , 1984, Journal of cellular physiology.

[387]  B. Zetter,et al.  Migration of cultured vascular cells in response to plasma and platelet-derived factors. , 1982, Journal of cell science.

[388]  R. Ross,et al.  Physiological quiescence in plasma‐derived serum: Influence of platelet‐derived growth factor on cell growth in culture , 1978, Journal of cellular physiology.

[389]  B. Fredholm,et al.  Modulation of arterial smooth muscle cells from contractile to synthetic phenotype requires induction of ornithine decarboxylase activity and polyamine synthesis. , 1987, Experimental cell research.

[390]  J. Thyberg,et al.  Phenotype modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor. , 1983, Differentiation; research in biological diversity.

[391]  M. Daemen,et al.  Alpha 1-adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta. , 1990, The Journal of biological chemistry.

[392]  G. Wendelschafer‐Crabb,et al.  Immunocytochemical localization of fibronectin (LETS protein) on the surface of L6 myoblasts: light and electron microscopic studies , 1978, Cell.

[393]  J. Thyberg,et al.  Plasma fibronectin promotes modulation of arterial smooth-muscle cells from contractile to synthetic phenotype. , 1987, Differentiation; research in biological diversity.

[394]  T. Wight,et al.  Cell biology of arterial proteoglycans. , 1989, Arteriosclerosis.

[395]  W. Shier Serum stimulation of phospholipase A2 and prostaglandin release in 3T3 cells is associated with platelet-derived growth-promoting activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[396]  R. Wickremasinghe The role of prostaglandins in the regulation of cell proliferation. , 1988, Prostaglandins, leukotrienes, and essential fatty acids.

[397]  R. Rosenberg,et al.  Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth , 1981, The Journal of cell biology.

[398]  M. Zerial,et al.  Identification of growth-factor-inducible genes in mouse fibroblasts. , 1988, Cold Spring Harbor symposia on quantitative biology.

[399]  G. Gabbiani,et al.  Vimentin-containing smooth muscle cells in aortic intimal thickening after endothelial injury. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[400]  W. Smith Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells. , 1986, Annual review of physiology.

[401]  O. Kocher,et al.  Analysis of alpha-smooth-muscle actin mRNA expression in rat aortic smooth-muscle cells using a specific cDNA probe. , 1987, Differentiation; research in biological diversity.

[402]  T. Ogihara,et al.  Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells. , 1990, Biochemistry international.

[403]  L. Kaczmarek Protooncogene expression during the cell cycle. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[404]  M. Hosang,et al.  Human Vascular Smooth Muscle Cells Have at Least Two Distinct PDGF Receptors and Can Secrete PDGF‐AA , 1989, Journal of cardiovascular pharmacology.

[405]  D. Belin,et al.  Actin isoform synthesis and mRNA levels in quiescent and proliferating rat aortic smooth muscle cells in vivo and in vitro. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[406]  P. Majerus,et al.  The metabolism of phosphoinositide-derived messenger molecules. , 1986, Science.

[407]  J. Vilček,et al.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[408]  D. Hajjar,et al.  Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity, and cholesterol metabolism. , 1989, Arteriosclerosis.

[409]  R. Ross,et al.  Two classes of PDGF receptor recognize different isoforms of PDGF. , 1988, Science.

[410]  E. Weber,et al.  Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. , 1990, Biochemical and biophysical research communications.

[411]  A. Clowes,et al.  Kinetics of Cellular Proliferation after Arterial Injury: IV. Heparin Inhibits Rat Smooth Muscle Mitogenesis and Migration , 1986, Circulation research.

[412]  R. Ross,et al.  The smooth muscle cell in culture. , 1979, Physiological reviews.